| Δ9-THC | Δ9-tetrahydrocannabinol |
| 2-AG | 2-araquidonilglicerol |
| 5HT1AR | serotonin receptor 1A |
| A2AR | adenosine receptor 2A |
| AEA | anandamide |
| BRET | bioluminescence resonance energy transfer |
| CB1R | cannabinoid receptor 1 |
| CB2R | cannabinoid receptor 2 |
| CBD | cannabidiol |
| CBG | cannabigerol |
| CNS | Central Nervous System |
| CVA | Cerebrovascular Accident |
| D2R | dopamine receptor 2 |
| DMH-CBD | Dimethyl-Heptyl-Cannabidiol |
| DOR | δ opioid receptors |
| eMCAO | embolic middle cerebral artery occlusion |
| FAAH | fatty acid amide hydrolase |
| GPCR | G protein-coupled receptor |
| HIE | Neonatal Hypoxic-Ischemic Encephalopathy |
| IFNg | interferon gamma |
| LPS | lipopolysaccharide |
| MCA | middle cerebral artery |
| mTBI | mild traumatic brain injury |
| MOR | µ opioid receptors |
| OGD | oxygen and glucose deprivation |
| PLA | proximity ligation assay |
| pMCAO | permanent middle cerebral artery occlusion |
| PPARγ | peroxisome proliferator-activated receptor gamma |
| ROS | reactive oxygen species |
| TBI | traumatic brain injury |
| TRPV1 | Transient Receptor Potential Vanilloid 1 |
| ZO-1 | tight junction protein zonula occludens-1 |